العربية
中国
Français
Deutsch
Ελληνική
हिन्दी
Italiano
日本語
Português
Русский
EspañolMALLINCKRODT
'Mallinckrodt Incorporated' is a set of pharmaceutical, chemical, imaging, and respiratory equipment suppliers based in the St. Louis, Missouri area, which were recently purchased by Tyco Healthcare (Tyco International) and which have been proposed for further reorganization.[1] One division, 'Mallinckrodt Baker', was produced by merger with the chemical supplier founded by John Townshend Baker.
Mallinckrodt is the sole legal source for cocaine in the United States, which it receives from a Stepan Company plant in Maywood, New Jersey, which is the only firm in the U.S. licensed to import coca leaves. Federal restrictions also bar the importation of drugs such as Esterom manufactured from cocaine, which therefore requires that they use this supplier.[2] Mallinckrodt is also one of the U.S. importers of opium from India.[3]
The Mallinckrodt General Clinical Research Center received contributions from 'Edward Mallinckrodt, Jr.', who headed the firm in the 1940s.
The legal decision Mallinckrodt, Inc. v. Medipart, Inc., 976 F.2d 700, 708 (Fed. Cir. 1992)) established a right of patent holders to limit the use of their products post-sale, and was cited in Arizona Cartridge Remanufacturers Association Inc. v. Lexmark International Inc., the decision that end-user licensing agreements on software boxes can be enforced against customers.
1. About Mallinckrodt
2. SEC filing by Esterom, Inc.
3. Feasibility Study on Opium Licensing in Afghanistan Senlis Council
★ Official site
Mallinckrodt is the sole legal source for cocaine in the United States, which it receives from a Stepan Company plant in Maywood, New Jersey, which is the only firm in the U.S. licensed to import coca leaves. Federal restrictions also bar the importation of drugs such as Esterom manufactured from cocaine, which therefore requires that they use this supplier.[2] Mallinckrodt is also one of the U.S. importers of opium from India.[3]
The Mallinckrodt General Clinical Research Center received contributions from 'Edward Mallinckrodt, Jr.', who headed the firm in the 1940s.
The legal decision Mallinckrodt, Inc. v. Medipart, Inc., 976 F.2d 700, 708 (Fed. Cir. 1992)) established a right of patent holders to limit the use of their products post-sale, and was cited in Arizona Cartridge Remanufacturers Association Inc. v. Lexmark International Inc., the decision that end-user licensing agreements on software boxes can be enforced against customers.
| Contents |
| References |
| External links |
References
1. About Mallinckrodt
2. SEC filing by Esterom, Inc.
3. Feasibility Study on Opium Licensing in Afghanistan Senlis Council
External links
★ Official site
This article provided by Wikipedia. To edit the contents of this article, click here for original source.
psst.. try this: add to faves
